Autoimmune/inflammatory optic neuropathy
MONDO:004468585 clinical trials for this condition and its sub-types, 0 tagged with Autoimmune/inflammatory optic neuropathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Autoimmune/inflammatory optic neuropathy
-
Neuromyelitis optica 85 trials
-
Isolated optic neuritis 0 trials
4 sub-types
-
Optic perineuritis 0 trials
-
Recurrent idiopathic neuroretinitis 0 trials
-
Experimental pill for rare nerve disease shows early promise in tiny trial
Disease control Stopped earlyThis early-phase trial tested the drug zanubrutinib in just 6 adults with neuromyelitis optica spectrum disorder (NMOSD), a rare condition where the immune system attacks the nerves. Participants took the pill twice daily for a year to see if it could prevent relapses. However, t…
Phase 2 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug aims to stop relapses in rare brain disease
Disease control Stopped earlyThis study tested an experimental drug called RC18 in 178 people with neuromyelitis optica spectrum disorders (NMOSD), a rare disease that causes inflammation in the eyes and spinal cord. The goal was to see if RC18 could prevent relapses and slow disability. Participants had to …
Phase 3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Russian NMOSD patients under the microscope: no new drug, just Real-World data
Knowledge-focused Stopped earlyThis study is not testing a new treatment. Instead, it observes how 100 adults with a rare autoimmune disease called NMOSD are managed in everyday Russian clinics. Researchers will collect medical records and follow patients over time to understand their symptoms, treatments, and…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC